Kazia's Paxalisib Study Shows Promising Responses in Advanced Breast Cancer—Is a New Therapeutic Option Emerging?
Market Chameleon (Tue, 27-Jan 9:11 AM)
Kazia’s $50 Million Private Placement Extends Cash Runway Into 2028: What This Means for Clinical Progress
Market Chameleon (Tue, 2-Dec 9:21 AM)
Kazia Therapeutics Delivers Rare Immune-Complete Response in Metastatic TNBC: What Sets This Milestone Apart?
Market Chameleon (Wed, 19-Nov 9:55 AM)
Kazia Therapeutics Reports Rare Immune-Complete Response in Stage IV Breast Cancer: What Does This Mean for Future Oncology Treatments?
Market Chameleon (Wed, 19-Nov 7:05 AM)
